- freely available
Familial Pancreatic Cancer
AbstractPancreatic cancer’s high mortality rate equates closely with its incidence, thereby showing the need for development of biomarkers of its increased risk and a better understanding of its genetics, so that high-risk patients can be better targeted for screening and early potential lifesaving diagnosis. Its phenotypic and genotypic heterogeneity is extensive and requires careful scrutiny of its pattern of cancer associations, such as malignant melanoma associated with pancreatic cancer, in the familial atypical multiple mole melanoma syndrome, due to the CDKN2A germline mutation. This review is designed to depict several of the hereditary pancreatic cancer syndromes with particular attention given to the clinical application of this knowledge into improved control of pancreatic cancer.
Share & Cite This Article
Lynch, H.T.; Lynch, J.F.; Lanspa, S.J. Familial Pancreatic Cancer. Cancers 2010, 2, 1861-1883.View more citation formats
Lynch HT, Lynch JF, Lanspa SJ. Familial Pancreatic Cancer. Cancers. 2010; 2(4):1861-1883.Chicago/Turabian Style
Lynch, Henry T.; Lynch, Jane F.; Lanspa, Stephen J. 2010. "Familial Pancreatic Cancer." Cancers 2, no. 4: 1861-1883.
Notes: Multiple requests from the same IP address are counted as one view.